ArticleJournal of personalized medicine2024

Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.

Nicoletta Bernardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.